Hydrogenology
Source-linked study record

Low-Flow Nasal Cannula Hydrogen Therapy

Sano M et al. · J Clin Med Res. 2020;12(10):674–680.

PreclinicalInhaled H₂Published 2020Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Spontaneously breathing micro miniature pigs

Intervention and dose

100% H₂ through a nasal cannula with a separate oxygen mask · 100% H₂ source gas.

Duration

Measurements during the first hour of inhalation

Reported result

Arterial H₂ concentrations rose during low-flow delivery in all three pigs. This was a delivery and pharmacokinetic experiment, not a disease-treatment or human clinical study.

Main limitation

Only three pigs, no comparator and no clinical outcome. Authors disclosed multiple patents related to H₂ delivery; the result cannot establish efficacy in people.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Uncontrolled large-animal pharmacokinetic feasibility experiment

Research topic

Respiratory health

Administration form

Inhaled H₂

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Spontaneously breathing micro miniature pigs

Sample

3 pigs

Duration

Measurements during the first hour of inhalation

Intervention

100% H₂ through a nasal cannula with a separate oxygen mask

Hydrogen form

H₂ alone from the generator; O₂ was supplied separately, not generated as Brown’s gas.

Dose or H₂ specification

100% H₂ source gas.

H₂ flow

250 mL/min H₂, directly reported.

O₂ delivered with H₂

O₂ was delivered separately by veterinary anesthesia equipment; the O₂ flow was not reported.

Comparator

No concurrent control group

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Arterial blood H₂ concentration and saturation; delivery feasibility

Reported result

Arterial H₂ concentrations rose during low-flow delivery in all three pigs. This was a delivery and pharmacokinetic experiment, not a disease-treatment or human clinical study.

Extraction completeness

Flow, device, methods, results, patents and conflicts checked in the free full text; independent appraisal remains incomplete.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Only three pigs, no comparator and no clinical outcome. Authors disclosed multiple patents related to H₂ delivery; the result cannot establish efficacy in people.

Applies directly to

Technical low-flow nasal-cannula delivery in anesthetized micro miniature pigs, not patients.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 33029275 · DOI: 10.14740/jocmr4323

Publisher access

Open-access full text is available through PMC.

Extraction basis

Open-access PMC full text and PubMed record.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.